
Adverse events of benralizumab in moderate to severe eosinophilic asthma
Author(s) -
Wanshu Liu,
Xuesu Ma,
Wenjin Zhou
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000015868
Subject(s) - medicine , benralizumab , relative risk , placebo , adverse effect , asthma , exacerbation , gastroenterology , confidence interval , mepolizumab , eosinophil , pathology , alternative medicine
Supplemental Digital Content is available in the text